SYENSQO 46.780 € (+3,06 %) AB INBEV 59.060 € (+0,10 %) ACKERMANS V.HAAREN 263.200 € (+0,84 %) GBL 76.050 € (+0,33 %) KBC 103.850 € (-0,48 %) ARGENX SE 587.000 € (-0,20 %) UCB 250.900 € (+0,93 %) TUBIZE-FIN 212.000 € (+1,19 %) NYXOAH 2.650 € (-2,21 %) SOFINA 215.800 € (-0,28 %) SOLVAY 25.320 € (+1,44 %) BARCO 9.560 € (+0,26 %) AZELIS GROUP 7.745 € (+3,96 %) UMICORE 16.180 € (+2,80 %) VGP 86.200 € (+0,70 %) ONTEX GROUP 4.095 € (-1,09 %) SHURGARD 25.300 € (+0,60 %) AGEAS 59.700 € (+0,67 %) QRF 11.050 € (+0,91 %) AEDIFICA 70.150 € (+0,94 %) WDP 22.600 € (+1,25 %) COFINIMMO 82.200 € (+1,17 %) ELIA GROUP 127.700 € (+0,79 %) D'IETEREN GROUP 162.200 € (+0,43 %) VASTNED 29.000 € (+0,35 %) MELEXIS 50.550 € (-0,69 %) ONWARD MEDICAL 3.520 € (0,00 %) LOTUS BAKERIES 9 700.000 € (+0,73 %) BEKAERT 39.850 € (+0,76 %) PROXIMUS 7.045 € (+1,81 %) MONTEA 65.600 € (+0,15 %) KBC ANCORA 69.500 € (-0,29 %) RECTICEL 9.100 € (-2,57 %) ECONOCOM GROUP 1.430 € (-1,24 %) ASCENCIO 49.750 € (+0,10 %) TINC 11.160 € (+0,36 %) TITAN S.A. 45.300 € (-0,11 %) FLUXYS BELGIUM D 21.000 € (+2,94 %) KINEPOLIS GROUP 25.150 € (+1,00 %) BIOTALYS 1.685 € (+1,51 %) CENERGY 18.380 € (+2,00 %) EKOPAK 4.220 € (-3,21 %) XIOR 26.850 € (+0,94 %) CELYAD ONCOLOGY 0.330 € (+0,30 %) DEME GROUP 183.200 € (-0,43 %) OPTION 7.000 € (+1,45 %) MOURY CONSTRUCT 710.000 € (+1,14 %) NEXTENSA 43.600 € (+1,63 %) CIE BOIS SAUVAGE 313.000 € (-1,57 %) GIMV 44.100 € (+0,80 %) WERELDHAVE BELGIUM 54.200 € (+0,74 %) HOME INVEST BE. 18.440 € (0,00 %) CMB.TECH 10.780 € (+1,13 %) FAGRON 21.800 € (+1,16 %) QUESTFOR GR-PRICAF 3.120 € (+1,94 %) RETAIL ESTATES 65.600 € (+2,02 %) EVS BROADC.EQUIPM. 32.750 € (0,00 %) BPOST 1.810 € (-0,55 %) CARE PROPERTY INV. 12.120 € (+0,83 %) AGFA-GEVAERT 0.463 € (-0,54 %)
ACCOR 40.580 € (+0,77 %)
AIRBUS 163.740 € (-1,60 %)
Vusion 105.100 € (-0,10 %)
HERMES INTL 1 664.000 € (+0,88 %)
SAFRAN 283.300 € (-1,39 %)
SENSORION 0.391 € (-4,63 %)
POXEL 0.236 € (-2,07 %)
ATEME 9.000 € (+6,89 %)
CELLECTIS 2.965 € (-1,66 %)
SHELL PLC 39.225 € (+1,10 %)
TOTALENERGIES 76.000 € (0,00 %)
STMICROELECTRONICS 26.635 € (-1,35 %)
RENAULT 27.970 € (-0,32 %)
SAINT GOBAIN 70.400 € (-0,59 %)
BUREAU VERITAS 26.120 € (+0,46 %)
UMG 15.710 € (-0,16 %)
VALNEVA 2.914 € (+4,82 %)
IMCD 77.940 € (+5,32 %)
ING GROEP N.V. 21.985 € (-0,48 %)
DANONE 68.380 € (+0,15 %)
HEINEKEN 66.220 € (+0,73 %)
MAGNUM 12.602 € (-0,65 %)
CAPGEMINI 97.400 € (-0,86 %)
AEGON 6.024 € (+0,10 %)
TELEPERFORMANCE 48.960 € (-1,11 %)
ARCELORMITTAL SA 44.370 € (+0,36 %)
RANDSTAD NV 24.040 € (+0,71 %)
THALES 237.800 € (-0,54 %)
AVANTIUM 6.700 € (+1,16 %)
SOLUTIONS 30 SE 0.774 € (-2,95 %)
NEXITY 7.865 € (+0,13 %)
PHILIPS KON 23.240 € (+0,74 %)
DASSAULT SYSTEMES 16.895 € (-0,65 %)
MAUREL ET PROM 10.240 € (-0,87 %)
LVMH 467.100 € (+0,11 %)
JCDECAUX 19.360 € (-0,36 %)
ALSTOM 23.820 € (-0,58 %)
BNP PARIBAS ACT.A 83.260 € (-0,11 %)
SCHNEIDER ELECTRIC 239.250 € (-1,66 %)
KERING 251.100 € (+2,41 %)
L'OREAL 351.700 € (+1,97 %)
ARGAN 60.700 € (+1,17 %)
MICHELIN 28.880 € (+0,70 %)
BOUYGUES 49.280 € (-0,04 %)
CREDIT AGRICOLE 16.150 € (-0,19 %)
ORANGE 17.115 € (+0,91 %)
CLARIANE 3.548 € (-2,74 %)
BE SEMICONDUCTOR 182.200 € (-0,19 %)
DSM FIRMENICH AG 58.900 € (+1,34 %)
AALBERTS NV 30.420 € (-0,26 %)
ASM INTERNATIONAL 670.400 € (+0,51 %)
KENDRION 17.040 € (+2,04 %)
RELX 28.980 € (+1,83 %)
GETLINK SE 17.480 € (+0,81 %)
ASML HOLDING 1 177.400 € (+0,17 %)
ADYEN 888.800 € (+1,24 %)
WOLTERS KLUWER 64.520 € (+1,10 %)
FORVIA 9.476 € (-1,09 %)
PEUGEOT INVEST 61.400 € (+0,16 %)
SOITEC 48.630 € (-6,19 %) News Réglementées
|
11/03/2026 09:00
Original-Research: Multitude AG (von NuWays AG): BUYOriginal-Research: Multitude AG - from NuWays AG Classification of NuWays AG to Multitude AG
Strong profitability expected, set to overachieve guidance Multitude will report its Q4’25 preliminary results tomorrow. Here is what to expect: Q4’25 interest income is expected to fall 7% yoy to €62.8m, driven by Consumer Banking, where interest income is projected to decline 14.7% yoy to €45.9m (eNuW). The decrease is explained by segment divestments realised in Q3’25 and by the lagged effects of a lower interest environment. As mentioned in our previous note, top line is likely to continue facing negative impacts through Q1'26, though a stable interest rate environment going forward should provide a solid base for an improvement in FY26e. In February, the ECB left its rates unchanged for a fifth consecutive time while projecting headline inflation at 1.9% for 2026, slightly down from 2.1% in 2025. A Reuters poll conducted on 9-12 February showed a strong consensus among economists, with 66 out of 74 expecting the deposit rate to stay at 2% at least through 2026. CapitalBox is seen increasing 1% yoy to € 9m (eNuW). The segment is also impacted by the aforementioned prior rate cuts. Further, CapitalBox operates in a rather soft market, as Eurostat data show business registrations up +0.5% qoq versus +2.5% qoq for bankruptcy declarations, suggesting macro‑driven volume pressure on top of the group’s deliberate de‑risking. Wholesale Banking, piloted in 2023, has quickly evolved into a strong growth avenue, that is set to increase 60% yoy to €7.9m (eNuW), on the back of an already strong performance in 9M’25 (+63.5% yoy). Here, Multitude targets overlooked deals outside the expertise of traditional banks, serving customers with specific, tailor‑made financing needs. The net fee and commission income is seen at € 4m, up 14.3% sequentially and nearly doubled yoy. The partnership business is highly net profit margin accretive, thanks to its capital-light and scalable setup. Mind you, the partnership model beat our estimates every quarter in FY25, where significant upside is still seen for FY26e with +39.7% yoy expected. On cost base, impairment losses are seen to continue on their long-term downward trend, declining 3.6% yoy to € 22m. Multitude’s loan book quality has been steadily improving over the years, as impairment levels have gone down from 31.5% to 15.2% in a seven-year span, despite the loan book increasing from € 468m to € 880m in the same timeframe. Net profit is seen at € 6.3m, reflecting a margin of 10% (eNuW). While this is a yoy decline from Q4’24 (€ 7.5m), it is acknowledged that the comparable quarter was very strong thanks to a more favorable interest rate environment. The Q4’25 results should nevertheless position Multitude to overachieve its full year net income guidance of € 24-26m, at € 26.5m. Dividends of €0.31 per share are expected (vs. €0.44 last year incl. a €0.20 extraordinary component). We do not make any changes ahead of the results and keep our BUY rating with a PT of € 11, based on our residual income model. You can download the research here: multitude-ag-2026-03-11-previewreview-en-64c50 For additional information visit our website: https://www.nuways-ag.com/research-feed Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse. ++++++++++ The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 2289272 11.03.2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||
© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière